首页> 外文期刊>Morbidity and Mortality Weekly Report: CDC Surveillance Summaries >Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic — 41 PEPFAR-Supported Countries, 2020
【24h】

Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic — 41 PEPFAR-Supported Countries, 2020

机译:COVID-19大流行期间在艾滋病毒服务提供方面取得的规划成果的经验教训——2020年总统防治艾滋病紧急救援计划支持的41个国家

获取原文
获取原文并翻译 | 示例

摘要

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) supports country programs in identifying persons living with HIV infection (PLHIV), providing life-saving treatment, and reducing the spread of HIV in countries around the world ( 1 , 2 ). CDC used Monitoring, Evaluation, and Reporting (MER) data * to assess the extent to which COVID-19 mitigation strategies affected HIV service delivery across the HIV care continuum † globally during the first year of the COVID-19 pandemic. Indicators included the number of reported HIV-positive test results, the number of PLHIV who were receiving antiretroviral therapy (ART), and the rates of HIV viral load suppression. Percent change in performance was assessed between countries during the first 3 months of 2020, before COVID-19 mitigation efforts began (January–March 2020), and the last 3 months of the calendar year (October–December 2020). Data were reviewed for all 41 countries to assess total and country-level percent change for each indicator. Then, qualitative data were reviewed among countries in the upper quartile to assess specific strategies that contributed to programmatic gains. Overall, positive percent change was observed in PEPFAR-supported countries in HIV treatment (5) and viral load suppression (2) during 2020. Countries reporting the highest gains across the HIV care continuum during 2020 attributed successes to reducing or streamlining facility attendance through strategies such as enhancing index testing (offering of testing to the biologic children and partners of PLHIV) § and community- and home-based testing; treatment delivery approaches; and improvements in data use through monitoring activities, systems, and data quality checks. Countries that reported program improvements during the first year of the COVID-19 pandemic offer important information about how lifesaving HIV treatment might be provided during a global public health crisis.
机译:美国总统艾滋病紧急救援计划(PEPFAR)支持国家计划,以识别艾滋病毒感染者(PLHIV),提供挽救生命的治疗,并减少艾滋病毒在世界各国的传播(1,2)。CDC使用监测、评估和报告(MER)数据*来评估COVID-19缓解策略在COVID-19大流行的第一年对全球HIV护理连续体†HIV服务提供的影响程度。指标包括报告的HIV阳性检测结果的数量、接受抗逆转录病毒治疗(ART)的艾滋病毒感染者人数以及HIV病毒载量抑制率。评估了2020年前3个月、COVID-19缓解工作开始前(2020年1月至3月)和日历年最后3个月(2020年10月至12月)各国绩效变化百分比。审查了所有41个国家的数据,以评估每项指标的总百分比和国家一级的变化。然后,对处于前四分之一的国家的定性数据进行了审查,以评估有助于方案收益的具体战略。总体而言,2020年,总统防治艾滋病紧急救援计划支持的国家在艾滋病毒治疗(5%)和病毒载量抑制(2%)方面观察到了积极的百分比变化。报告2020年艾滋病毒护理连续体中进展最大的国家将成功归因于通过加强指数检测(向艾滋病毒感染者的亲生儿童和伴侣提供检测)§以及社区和家庭检测等战略减少或简化设施出勤率;治疗方法;以及通过监控活动、系统和数据质量检查来改进数据使用。在COVID-19大流行的第一年报告了项目改进的国家提供了关于在全球公共卫生危机期间如何提供挽救生命的艾滋病毒治疗的重要信息。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号